コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d predicting the effects of pulse warming on parasitic infection.
2 igher background rate of eosinophilia due to parasitic infection.
3 expression was up-regulated in response to a parasitic infection.
4 to humans and an important blood-borne human parasitic infection.
5 the drug discovery pipeline for this deadly parasitic infection.
6 omponents of the innate immune system during parasitic infection.
7 egral link in the chronic immune response to parasitic infection.
8 e important in Th2 cell-mediated immunity to parasitic infection.
9 tripartite model for nematode parasitism and parasitic infection.
10 beta induction and other markers of viral or parasitic infection.
11 the CD8(+) T cells during both a viral and a parasitic infection.
12 -49 receptor-expressing NK cell subsets in a parasitic infection.
13 -helper cells may be modulated by concurrent parasitic infection.
14 arthenogenetic Daphnia magna with respect to parasitic infection.
15 diated immune responses for an intracellular parasitic infection.
16 facilitate recognition and treatment of this parasitic infection.
17 tic doses to animals to selectively arrest a parasitic infection.
18 tion of the IgE response to allergens and to parasitic infection.
19 imates for a variety of conditions including parasitic infection.
20 of visceral leishmaniasis (VL) is a zoonotic parasitic infection.
21 ease globally in parallel with a decrease in parasitic infection.
22 kk-1) upon allergen challenge or non-healing parasitic infection.
23 allergic inflammation and protection against parasitic infection.
24 the liver that can determine the outcome of parasitic infection.
25 region occurred for select diagnoses such as parasitic infections.
26 eir contribution to enhance host exposure to parasitic infections.
27 ify new treatments for asthma, allergies and parasitic infections.
28 with high peanut consumption and widespread parasitic infections.
29 skin reactivity), consumption patterns, and parasitic infections.
30 ses, IL-17E is essential for defense against parasitic infections.
31 reatment of cancer, heart disease, AIDs, and parasitic infections.
32 ulating intracellular bacterial, fungal, and parasitic infections.
33 llular infiltrate associated with asthma and parasitic infections.
34 ty-adjusted life year (DALY), is unsuited to parasitic infections.
35 reatment of cancer, heart disease, AIDS, and parasitic infections.
36 reatment of cancer, heart disease, AIDS, and parasitic infections.
37 tokine production and protective immunity to parasitic infections.
38 in parasite epidemiology and the control of parasitic infections.
39 therapeutics for the treatment of cancer and parasitic infections.
40 plain many immune features characteristic of parasitic infections.
41 n allergic diseases and the host response to parasitic infections.
42 ng and managing the area-wide elimination of parasitic infections.
43 model for the study of human and veterinary parasitic infections.
44 novel drug targets and vaccine candidates in parasitic infections.
45 d an APOL3 variant involved in resistance to parasitic infections.
46 tor used for the prevention and treatment of parasitic infections.
47 tion of eosinophils in allergic diseases and parasitic infections.
48 eripheral blood T cells during bacterial and parasitic infections.
49 ment of eosinophils in allergic diseases and parasitic infections.
50 e and may confer physiological protection in parasitic infections.
51 cancers associated with bacterial, viral, or parasitic infections.
52 an attractive drug target for the control of parasitic infections.
53 diated disorders such as allergy, atopy, and parasitic infections.
54 angiogenesis and cancer to inflammation and parasitic infections.
55 in the initial suppression of bacterial and parasitic infections.
56 er, metabolic diseases as well as fungal and parasitic infections.
57 sights into these remarkable determinants of parasitic infections.
58 individuals, including the susceptibility to parasitic infections.
59 ownstream target of Rboh-mediated ROS during parasitic infections.
60 s of lower gastrointestinal bleeding such as parasitic infections.
61 allergic inflammation and protection against parasitic infections.
62 ment of T-cell malignancies and/or bacterial/parasitic infections.
63 uding solid and hematologic malignancies and parasitic infections.
64 uring Th2-mediated immune responses, such as parasitic infections.
65 kers, is a common occurrence in HIV and some parasitic infections.
66 both human and veterinary medicine to treat parasitic infections.
67 eactive protein levels and low prevalence of parasitic infections.
68 idation set including individuals with other parasitic infections.
69 rfusion injury, enteroinvasive bacterial and parasitic infections.
70 s a possible source for symptom disparity in parasitic infections.
71 lt in flare-ups of many bacterial, viral and parasitic infections.
72 ron metabolism and the etiology of anemia in parasitic infections.
73 odulatory functions in allergic diseases and parasitic infections.
74 mmune responses during viral, bacterial, and parasitic infections.
75 n diverse diseases from cancer to eukaryotic parasitic infections.
76 rological diseases and disorders, as well as parasitic infections.
77 nt specimens with other viral, bacterial, or parasitic infections.
78 including aggressive cancer, arthritis, and parasitic infections.
80 ival were less likely to screen positive for parasitic infections (9.6% versus 12.2%; adjusted preval
81 herpes viruses, mycobacteria, and fungal and parasitic infections, a single arm of the immune respons
82 in the past year fatal viral, fungal, and/or parasitic infections accounted for 16% and 34% of the mo
83 s bacterial peptidoglycan, viral infections, parasitic infections, activated Rho GTPases, and endopla
84 ted for centuries as chronically disfiguring parasitic infections affecting millions of people across
85 ed exposure to stressors (viruses, bacteria, parasitic infections, alcohol, drugs) or genetic mutatio
86 ory states arising from viral, bacterial and parasitic infection, allergic and asthmatic reactions, a
87 The pathological process was recognised as a parasitic infection, although its features were differen
91 response able to clear bacterial, viral, and parasitic infection and an ability to efficiently store
93 ation of IFN-gamma-mediated immunity to this parasitic infection and identify a novel function for th
95 result of incomplete surgery due to extended parasitic infection and liver anathomical changes due to
96 complexity of the murine host response to a parasitic infection and suggest that an outbred human po
97 rinary and human medicine for the control of parasitic infection and was the joint focus of the 2015
98 s that regulate both protective responses in parasitic infections and allergic airway inflammation.
102 icle, we review the current understanding of parasitic infections and basophils and discuss their put
103 Chronic inflammatory conditions such as parasitic infections and cancer trigger a metabolic repr
105 retroviruses (ERVs) are remnants of ancient parasitic infections and comprise sizable portions of mo
106 pathophysiological basis of the link between parasitic infections and epilepsy, and we consider preve
107 ne treats and prevents several bacterial and parasitic infections and has been proposed as a possible
109 4-dependent, Th2-mediated responses in other parasitic infections and in models of allergic asthma, t
110 reports on the exact roles for IL-17 during parasitic infections and limited knowledge about cellula
111 Eosinophil recruitment is a hallmark of parasitic infections and many forms of cancer, and eosin
112 This approach may find useful application in parasitic infections and more broadly in any disease sta
114 for their ability to facilitate clearance of parasitic infections and their association with asthma a
116 rnivore scavenging strategies under risks of parasitic infection, and (iii) conducting a literature-r
119 te that CD4+ TRM cells form in response to a parasitic infection, and indicate that optimal protectiv
120 ied a novel inhibitory function for IL-17 in parasitic infection, and our results demonstrate importa
121 52 days) elapsed before the first documented parasitic infection, and the median intervals from arriv
122 y recruited into the CNS in response to this parasitic infection, and they were able to target the in
123 on exhibited elevated pathogen burden during parasitic infection, and this could be rescued by transf
124 g, 34 serum samples from patients with other parasitic infections, and 15 normal human serum samples.
126 ector functions during bacterial, viral, and parasitic infections, and contributed to innate response
128 admission included malnutrition and wasting, parasitic infections, and haematological disorders in th
130 eptors have not been investigated to date in parasitic infections, and little is known about the role
131 loped because they are already used to treat parasitic infections, and there is interest in their use
133 tion of drugs against bacterial, fungal, and parasitic infections, antineoplastic agents against canc
134 The pathological processes resulting from parasitic infection are known to have important impacts
141 capable of preventing viral, bacterial, and parasitic infections are currently under development.
143 better management of malaria and intestinal parasitic infections are likely to reduce the incidence
146 s review focuses on studies that use enteral parasitic infections as a tool to investigate the functi
147 iety of noxious environmental substances and parasitic infections at epithelial barrier surfaces.
148 pic cytokine involved in allergic reactions, parasitic infections, autoimmune inflammation, and cance
150 ignature appear during viral, bacterial, and parasitic infections, but also arise during humoral auto
151 number of enteric infections, including many parasitic infections, but also likely provide protection
153 may lead to new therapies for microbial and parasitic infections, cancer, and neurodegenerative dise
157 Schistosomiasis or snail fever is an endemic parasitic infection caused by various trematodes of the
160 nological rationale underpinning therapeutic parasitic infection, describe recently initiated trials,
161 atopoietic growth factors or emerging during parasitic infections, display tolerogenic properties.
163 effect of stunting, diarrhoeal disease, and parasitic infections during infancy on cognitive functio
164 ous congenital infections, the mechanisms of parasitic infections during pregnancy remain poorly unde
165 incidence and natural history of intestinal parasitic infections during the PCVs' >2-year overseas s
166 y, the mechanisms by which mosquitoes resist parasitic infection (e.g., immune-mediated killing) have
167 mass drug administration (MDA) against these parasitic infections emphasise treatment of school-aged
175 a chronic inflammatory disease diabetes and parasitic infection helminth as illustrativedisease pair
176 ntestinal type 2 immunity to protect against parasitic infections, highlighting the role of p53 as a
178 ective innate immunity against bacterial and parasitic infections; however, its role in host immunity
179 rovided insight into innate immunity against parasitic infections; however, species-specific differen
180 adpoles leads to increased susceptibility to parasitic infection in adult frogs, in the absence of su
182 undisputable, we know very little about how parasitic infection in reproductive females might influe
183 utaneous leishmaniasis (CL) is a very common parasitic infection in subtropical areas worldwide.
184 rovide possible explanations for the role of parasitic infection in susceptibility and resistance to
192 across age, sex, anthropometric indexes, and parasitic infections in a representative sample of 3595
194 chronic infection is one of the most common parasitic infections in humans and can be reactivated to
197 T cell differentiation and susceptibility to parasitic infections in murine models, we compared T cel
198 tervention addressing 2 of the most virulent parasitic infections in pregnant women in sub-Saharan Af
199 osomiasis are the world's two most important parasitic infections in terms of distribution, morbidity
200 risk of common bacterial, viral, fungal, and parasitic infections in the general population of indivi
202 tudies toxoplasmosis, one of the most common parasitic infections in the world, caused by Toxoplasma
205 at can protect against bacterial, viral, and parasitic infections, including lethal influenza and mal
206 th a broad-spectrum activity against various parasitic infections, including malaria, toxoplasmosis a
207 vaccines are available for human use for any parasitic infections, including the helminthic disease s
209 o Leishmania major (Lm) or Toxoplasma gondii parasitic infections, indicating that exogenously delive
210 DACs may show benefits in diseases (cancers, parasitic infections, inflammatory conditions) where AR-
213 The direct benefit to females of avoiding parasitic infection is proposed to lead to the linkage b
218 addition, use of nephrotoxic drugs to treat parasitic infections is associated with acute kidney inj
223 s and those chronic and debilitating (mostly parasitic) infections known as neglected tropical diseas
224 d neoplastic (chronic lymphocytic leukemia), parasitic infection (Leishmania major), and infectious d
227 This review discusses T cell exhaustion in parasitic infection, mechanisms of development, and a po
229 ost defense in viral, bacterial, fungal, and parasitic infections, myeloid CLRs have been implicated
230 r regulation of immune responses, such as in parasitic infection, necessitate further characterizatio
232 sent potential mechanistic pathways by which parasitic infection of mother and/or infant may lead to
237 ing the model, we linked negative effects of parasitic infection on host survival, fecundity, and fee
238 tion problems, particularly the influence of parasitic infections on child health and nutrition.
240 munity that can either be protective against parasitic infection or cause tissue damage in allergy an
241 patients affected by Th2 pathologies such as parasitic infections or atopic dermatitis often suffer f
244 esults are negative, O&P can be performed if parasitic infections other than G. lamblia, E. histolyti
245 ory antibody responses within the context of parasitic infections, our results suggest that PfGARP mi
246 ietary factors such as chronic inflammation, parasitic infections, overweight, and genetic hemoglobin
247 l established risk factors for CC, including parasitic infections, primary sclerosing cholangitis, bi
248 sed by granulomatous disorders, DNA viruses, parasitic infections, pulmonary amyloidosis, vascular ca
250 ationship was mostly explained by fungal and parasitic infections rather than by viral and bacterial
256 -human primates have consistently found that parasitic infections result in less movement and reduced
258 sease settings such as bacterial, viral, and parasitic infections, sepsis, obesity, trauma, stress, a
259 dation of immune mechanisms underpinning the parasitic infections, some of which are parasite-specifi
260 ve disease, including hallmark signatures of parasitic infection such as elevated immunoglobulin G4 (
261 wever, the role of NK cells in extracellular parasitic infections such as filarial infections is not
266 ogen clearance in many bacterial, viral, and parasitic infections, such as through Toll-like receptor
270 n people are at risk of acquiring malaria, a parasitic infection that produces more than 200 million
272 caused by Trypanosoma brucei gambiense is a parasitic infection that usually progresses to coma and
273 l burden of high E4 prevalence combined with parasitic infections that can also reduce cognitive perf
274 e habitat for intermediate hosts of tropical parasitic infections that cause disease and suffering.
275 sis may have potential utility for targeting parasitic infections that cause important neglected trop
276 ons of cell death on the outcome of numerous parasitic infections that impact the brain, meninges, an
277 e been proposed by which hosts can withstand parasitic infections, the role of multiple infections an
278 e natural antimicrobial mixture (AG) reduced parasitic infections through mechanisms that reduced pat
280 rheal episodes, the continued acquisition of parasitic infections throughout the PCVs' >2-year stay i
281 rol patients who had other parasitic and non-parasitic infections to a weak cation exchange chip, and
283 ania infantum, is a persistent intracellular parasitic infection transmitted by the bite of infected
287 lations with a high prevalence of intestinal parasitic infections, two independently collected stool
288 d is induced in response to inflammation and parasitic infections, upon exposure to microbiota, and i
289 d mortality associated with these intestinal parasitic infections warrant the development of rapid an
290 ed modelling showed that only positivity for parasitic infections was a significant predictor of redu
292 dazole, an oral drug currently used to treat parasitic infections, was used as a positive control.
294 n thus offers an example of an intracellular parasitic infection where CD8(+) T-cell immunity can be
295 f reproductive age are currently at risk for parasitic infection, whereas many pregnant, chronically
296 s suggests an innate immune response against parasitic infections, whereas the other gene expression
297 iotic used in veterinary medicine to prevent parasitic infections which also displays potent inhibito
298 r without Schistosoma mansoni coinfection, a parasitic infection with T helper (Th) 2 immune bias.
300 The physiological effects of such events on parasitic infections within endotherms are poorly studie